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Summary
Objective: Evaluation of the internal construct validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index
adapted for use in patients with femoro-acetabular impingement (FAI) and osteoarthritis (OA) of the hip.
Methods: Distribution of a German version of WOMAC to patients upon ﬁrst consultation. Patients with FAI [n¼ 100, mean age 31.7 years,
standard deviation (SD) 9.7] and OA (n¼ 57, mean age 60.3 years, SD 11.7) and without comorbidities or prior hip surgery were included and
compared to age- and gender-matched control population to FAI (n¼ 200, mean age 32.6 years, SD 5.6). WOMAC data of 157 questionnaires
were evaluated by Rasch analysis using RUMM2020 software.
Results: Summation of total WOMAC shows misﬁt to the Rasch model as well as multidimensionality. While the pain subset shows adequate
ﬁt and is unidimensional, item reduction is required to ﬁt a unidimensional subset of functional items to the Rasch model. Summating the two
ﬁtting subsets yields again slight model misﬁt and multidimensionality requiring further item reduction. Finally, a 12-item version of the total
WOMAC shows good model ﬁt and unidimensionality, i.e., internal construct validity, for assessment of patients with FAI and OA without
differential item functioning (DIF). A person separation index (PSI)¼ 0.93 indicates a high internal consistency reliability for the 12-item sub-
scale. Scores for FAI are signiﬁcantly higher than control (P< 0.001, effect size 0.71) and lower than OA group (P< 0.001, effect size 0.45).
Adequate statistical power is shown discriminating the three groups, therefore indicating some evidence also for external construct validity.
Conclusions: The WOMAC as a total construct is multidimensional and summating the subsets into a total score is not valid. The reduced
12-item WOMAC is demonstrated to have internal construct validity for assessing patients with FAI and OA on the same scale and high
internal consistency reliability. Discrimination of the groups with adequate statistical power also indicates external construct validity.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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At the present, no outcome measure or scoring system
exists which shows internal construct validity for measuring
impairment or activity limitation for patients suffering from
femoro-acetabular impingement (FAI) of the hip, a form of
pre-arthritic hip disease which has recently been
described1. With increasing recognition of this and other
pre-arthritic disorders and with advanced surgical treatment
options2,3, a clinical instrument for patient and outcome
assessment is needed.
There are a wide variety of traditional hip scores which
may, or may not be suitable for this task, but lack validity
in assessing patients with FAI. For example, the use of
SF-36 and the Modiﬁed Harris Hip Score have been
proposed for evaluating patients after hip arthroscopy4,5.
However, these scores have not been validated in terms*Address correspondence and reprint requests to: Dr Dominique
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1032of construct validity for FAI patients but rely on a theoreti-
cally non-existing criterion measure4e6. Furthermore, most
of these traditional outcome measures are ordinal in nature
giving ordinal ‘manifest’ scores which preclude arithmetic
operations, such as the calculation of change scores or
effect sizes and parametric statistical tests7, which
nevertheless seem to be carried out frequently4,5,8. As eval-
uation programmes typically wish to calculate change
scores, this presents a signiﬁcant challenge to the ortho-
paedic community. In addition, many of the scales available
are limited in their evidence for basic attributes such as
unidimensionality.
As a fundamental requirement of construct validity9,
unidimensionality of a scale needs to be shown for summat-
ing any set of Likert-style items7,10. Thus all candidate
scales for assessing the outcome of interventions for FAI
must demonstrate construct validity for this condition, in-
cluding unidimensionality. Furthermore, given the expected
use, some transition to interval scaling is required to support
the calculation of change scores.
Rasch analysis provides a method to ensure that scales
are unidimensional11. When data meet the expectation of
this model, a transformation of the ordinal raw score into
Table I
Patient characteristics
Healthy control FAI OA
n 200 100 57
Age 32.6 5.6 31.7 9.7 60.3 11.7
Male 99 (49.5%) 45 (45%) 28 (49%)
Female 101 (50.5%) 55 (55%) 29 (51%)
Sports 170 (85%) 83 (83%) 35 (61%)
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assumes that the probability of a patient afﬁrming an item
is a logistic function of the relative distance between the
item location and the patient location on the same linear
scale. Thus, for example, the probability that a person will
afﬁrm an item measuring pain is a function of the difference
between the patient’s level of pain and the level of pain
expressed by the item.
Fitting the data to the Rasch model places both item and
person parameter estimates on the same scale and gives
a linear transformation of the raw score. The score is thus
translated from a manifest observed score into a latent
interval-level measure score using the logit (log odds unit)
as the unit of measurement11.
Due to its wide spread use, the Western Ontario and
McMaster Universities (WOMAC) Osteoarthritis Index pres-
ents an interesting starting point for use in FAI patients.
Here, we sought to evaluate internal construct validity,
i.e., linearity and unidimensionality, of the full version for
use in patients with FAI and osteoarthritis (OA) of the hip.
Data from the scale were subjected to Rasch analysis to
investigate if the WOMAC shows ﬁt to the Rasch model
for use in these patients. In contrast to previously proposed
short versions of the WOMAC12,13, reduction of the scale
was required to fulﬁl the requirements for internal construct
validity as a consequence of misﬁt to the Rasch model and
a breach of the principle of unidimensionality of the full
scale, rather than for example, practicability. Thus, we
propose a 12-item version of the WOMAC which fulﬁls the
fundamental requirements for summation and calculation
of change scores and provides some evidence of external
construct validity for use in evaluation of patients with FAI
and OA of the hip.MethodsPATIENTSA self-administered questionnaire consisting of a German version of the
WOMAC with items for pain (5 items), physical function (17 items) and
stiffness (2 items) was distributed to 200 patients upon their ﬁrst consulta-
tion and data collected prospectively. The full version of the WOMAC was
chosen, because it is widely used and because it would allow item reduc-
tion, if necessary in the case of model misﬁt of the full scale. All items were
graded on a 7-point Likert-scale because it was believed that a higher
resolution (than the original 5-point scale) may be necessary to assess
pre-arthritic hip patients with FAI. Inclusion criteria were for FAI a positive
anterior or posterior impingement test, correlated pathomorphology of the
hip radiographically (decreased offset, femoral head asphericity and/or
deep retroverted acetabulum) and by arthro-MRI and no radiographic signs
of OA (joint space loss, hypersclerosis, cysts, osteophytes) according to
To¨nnis et al.14. OA was diagnosed by clinical examination and radiography
(To¨nnis grade> 1). For FAI and OA, only patients without prior hip surgery
and no comorbidities which may have impaired ambulation or elicited pain
were included. The questionnaire was distributed to 200 patients meeting
the inclusion criteria between January and December 2006 upon their ﬁrst
ofﬁce visit. Of the 200 administered questionnaires, 157 were ﬁlled in
completely and could therefore be used for further analysis. Forty-three
questionnaires had to be excluded, because missing data does not allow
calculation of the complete score. Out of the 157 patients, 100 were diag-
nosed with FAI and 57 with OA (Table I). Eighty-four patients were female
(55 FAI, 29 OA) and 73 male (45 FAI, 28 OA). One hundred and eighteen
patients indicated that they participated in sporting activities (83 FAI, 35
OA) while 39 patients did not (17 FAI, 22 OA). The mean age among all
FAI patients is 31.7 9.7 years (ranging from 13 to 42) and among all
OA patients 60.3 11.7 years (from 34 to 85) (Table I). The WOMAC is
distributed routinely to patients at our institution, which is approved by
the institutional review board. Patients have agreed that the data be
used anonymously for outcome studies.
As a control normal population to the FAI patient population, an age- and
gender-matched sample of 200 patients without hip pain was randomly
selected out of a pool of 16,191 questionnaires used to develop a musculo-
skeletal Standard Evaluation Questionnaire15. The ﬁnal 12 items were trans-
formed from logits back to integer values ranging from 0 to 4 for 5-responseitems and 0 to 3 for the one item with 4-response options, and ﬁnally
summed up and statistically compared as described below.RASCH ANALYSISTo test how well the observed data ﬁt the expectations of the measure-
ment model, data are ﬁtted to the Rasch model using RUMM2020 soft-
ware (RUMM Laboratory, Perth, Australia). Using an analytical strategy
previously described10, ﬁt to the model was determined by calculating
itemeperson interaction statistics transformed to approximate a z-score.
Perfect ﬁt to the model is therefore represented by a mean of approxi-
mately zero and a standard deviation (SD) of 1. In addition, an itemetrait
interaction statistic to test the property of invariance across the trait is cal-
culated as a chi square. If signiﬁcant, the chi square indicates that the
hierarchical ordering of the items varies across the trait and therefore
compromises the required property of invariance. As an estimate of inter-
nal consistency RUMM2020 calculates a person separation index (PSI)
where the estimates on the logit scale for each person are used for
calculation.
In order to resolve misﬁt to the model, individual person and item ﬁt
statistics are investigated. Residuals between 2.5 indicate adequate ﬁt of
the person’s responses to the model. Respondents with ﬁt residuals outside
of this interval may be discarded, because a few respondents deviating from
model expectation may cause signiﬁcant misﬁt at the item level, possibly due
to some unrecorded co-morbidity of the particular patient. In the case of
individual item ﬁt, the overall chi square for each item is calculated, signiﬁ-
cant values indicate misﬁt of the individual item to the model. To take
account of multiple testing, Bonferroni corrections are applied to adjust the
chi square P-value16. In addition, misﬁt of the item responses to the model
can be visualised graphically with an item characteristics curve (ICC).
Observed model ﬁt for groups of responders across the trait are plotted
against the expected model curve. Items with good ﬁt will show each of
the group plots lying on the curve.
Further investigation of sources of deviation from model expectation to
see whether the scale construct can be improved encompasses checking
of threshold ordering. Threshold refers to the point between two response
categories where either response is equally probable. It is expected for
a good ﬁtting model that for each of the items, respondents with high levels
of the attribute being measured would endorse high scoring responses, while
individuals with low levels of the attribute would consistently endorse low
scoring responses. Responses to an item are investigated using category
probability curves, which may reveal disordered thresholds as a source of
item misﬁt, i.e., failure of respondents to use the response categories in
a manner consistent with the trait being measured. Where disordered thresh-
olds are found, response options are collapsed and the item rescored which
may improve item ﬁt to the model. Response options are collapsed in
RUMM2020 by assigning potentially redundant response options to another
such that ordered thresholds result, thereby reducing the total number of
possible responses to an item.
Another issue which may affect model ﬁt is a form of item bias known as
differential item functioning (DIF). This occurs when different groups within
the sample respond in a different manner to an individual item, e.g., males
and females, different age groups or patients doing sports vs patients not
doing any sports. To detect the presence of DIF, analysis of variance
(ANOVA) is carried out for each item comparing scores across each level
of the person factor (e.g., gender, age group etc.) and across different levels
of the trait. DIF is indicated by a signiﬁcant main effect for the person factor or
by a signiﬁcant interaction effect.
A scale is expected to be unidimensional, i.e., to measure only one under-
lying concept. Consequently testing for multidimensionality needs to be
conducted at each level of analysis for model ﬁt, threshold disordering and
DIF. This involves a principal components analysis (PCA) of the residuals
and allowing the factor loadings of the ﬁrst residual to determine contrasting
subsets of items, which are then tested by a independent t tests to see
whether the person estimate derived from these subsets signiﬁcantly differ
from each other17. If the person estimate is found to differ between the sub-
sets this would indicate a breach of the assumption of local independence
and consequently the unidimensionality of the scale. Unidimensionality is
supported if the independent t test is signiﬁcant (with Binomial Conﬁdence
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size.STATISTICSStatistical testing to compare logit values of the total score for those
involved with sports, or not, and for disease type, was carried out directly in
RUMM2020 by ANOVA. The KolmogoroveSmirnof test and t test were
performed using the R statistics package (R Foundation, http://www.r-project.
org). Effect size was calculated using the formula r ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðt2=ðt2 þ dfÞÞp . Power
analysis was carried out using the software G*Power, available for free from
the Heinrich-Heine University, Du¨sseldorf, Germany.ResultsOVERALL FIT OF MODIFIED WOMAC TO THE RASCH MODELFor initial analysis, the thresholds had to be rescored
back to their original 5-point scale, because the 7-point
scale showed threshold disordering in all but 6 items and
thus did not reliably discriminate between response options
[Fig. 1(a)]. The intention of adding resolution by introducing
a 7-point scale is therefore not supported by the data and
rather confuses patients’ responses. After collapsing the
categories back to a 5-point response using RUMM2020,
i.e., from a 0123456 structure to 0112234, ordered thresh-
olds resulted for all items and model ﬁt was investigatedFig. 1. Category probability curves for item ‘‘pain walking’’. (a) 7-
Response options result in disordered thresholds. (b) Rescoring
to 5-response options results in ordered thresholds, which is the
appropriate curve pattern for items included in the 12-item scale.
After rescoring, all included items had category probability curves
similar to the one shown.[Fig. 1(b)]. The total WOMAC shows misﬁt to the Rasch par-
tial credit model for the FAI and OA patient groups as well
as both patient groups combined, with a signiﬁcant chi
square interaction and a poor individual person ﬁt and mar-
ginal item ﬁt (Table II). The independent t test for unidimen-
sionality is signiﬁcant in approximately 20% of the cases
indicating a multidimensional construct. Thus a total WO-
MAC score is not supported by this analysis. Consequently,
the items are split into subsets (pain and function) and fur-
ther analysed and adjusted in order obtain a modiﬁed score
which shows ﬁt to the Rasch model. Because the overall
summed score did not show any DIF for the person factor
disease, i.e., patients with FAI and OA respond in the
same way, the data of FAI and OA patients were pooled
for all further analysis.SUBSET OF PAIN ITEMSAfter rescoring items from a 7-point scale to the original
5-point scale all thresholds but for item 4 (pain walking
ﬂat) were ordered. Thus item 4 was rescored to a 4-point
scale. The summary statistics for the pain subset after
threshold ordering are given in Table III analysis 1 and
indicate adequate ﬁt of the pain subset to the model, and
indicating strict unidimensionality with just 2.99% signiﬁcant
independent t tests. Individual item ﬁt seems appropriate
(Table IV). Investigation of person ﬁt to the model indicates
no extreme ﬁt residuals. No DIF can be detected for gender,
age group and sports, which means that responses to all
the pain items do not differ within these groups. Only for
item 3 (pain sitting/lying) DIF could be detected for the
person factor disease (Fig. 2). Patients with FAI therefore
respond differently to this item than patients with OA. If
the construct is to be used in both patient groups and
scores are to be compared, then adjustment will need to
be made for this difference, or the item removed from further
analysis. After removal, the remaining four items still show
an adequate ﬁt to the model and represent a unidimensional
construct (Table III, analysis 2).SUBSET OF FUNCTION ITEMSInitial analysis after rescoring of the subset of function
items shows misﬁt to the Rasch model as well as multidi-
mensionality in the construct (Table III, analysis 3). To
identify sources of multidimensionality which may also
cause model misﬁt, individual item ﬁt was checked. Items
7 (lying in bed), 24 (heavy chores) and 25 (light chores)
were indicated to have a signiﬁcant chi square statistic after
Bonferroni correction and are thus omitted in the subse-
quent analyses. In addition, three respondents were
identiﬁed which do not meet the criteria for individual person
ﬁt and are also excluded from further analyses. The result-
ing ﬁt statistic is given in Table III, analysis 4 and fails to
show improved ﬁt to the model. Analysis of the residual
correlations matrix between the items revealed that there
are high correlations among all the items which involve
some kind of bending over movement (items 20e22,
bending, putting on/off socks), suggesting that they may
act as a second underlying concept and therefore introduce
multidimensionality. Removal of these items improved ﬁt to
the model and reduced multidimensionality of the construct
(Table III, analysis 5). Fit to the model still is marginal
because of the high SD in the item ﬁt residual. Item 18
(getting on/off toilet) still shows a high ﬁt residual, the ﬁt sta-
tistic is therefore recalculated without this item. Removing
Table II
Rasch model fit statistics of original WOMAC
Analysis Item ﬁt residual Person ﬁt residual Chi square interaction PSI t Tests (CI) (%) n
Mean SD Mean SD Value (df) P
FAI 0.123 1.298 0.118 1.403 86.107 0.000607 0.94873 21.65 98
OA 0.313 1.154 0.367 2.001 78.332 0.00371 0.94269 18.87 56
FAI and OA 0.124 1.681 0.309 1.73 135.373 0.000001 0.94791 22.00 154
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and item ﬁt residual. Only 3.79% of t test were signiﬁcant,
indicating a unidimensional construct. Item ﬁt residuals for
the remaining items in the subset are given in Table IV.
No DIF could be detected in the reduced subset for all
person factors.SUBSET OF ITEMS FOR STIFFNESSWith only two items for stiffness, a meaningful analysis
cannot be carried out. Fit residuals for the two stiffness
items show misﬁt to the Rasch model (data not shown). In
addition, 49 patients were excluded from the analysis by
the software due to extreme values. When the stiffness
items are added to either the pain subset or the functional
subset, multidimensionality is introduced (data not shown).
Stiffness items were therefore excluded for further analysis.COMBINATION OF ADJUSTED PAIN AND FUNCTION SUBSETSThe two reduced subsets of pain and function items were
further combined into a 15-item scale to see whether
a higher construct reﬂecting a summation of the items can
be generated. The initial analysis shows slight misﬁt to
the Rasch model and multidimensionality as indicated by
the t tests (Table III, analysis 7). Therefore the two subsets,
previously ﬁtting the Rasch model, cannot be combined into
a higher construct by simply adding up the items. Investiga-
tion of individual item ﬁt reveals a high ﬁt residual and
probability below the Bonferroni adjustment for item 1 (night
pain). Analysis of individual person ﬁt shows six respon-
dents with ﬁt residuals outside of the interval of 2.5, but
their removal only slightly improves person ﬁt to the model
(Table III, analysis 8), although it reduces the signiﬁcant t
tests to 11.43%. Furthermore, there are residual correla-
tions between items 10 and 11 (arising from sitting andTable I
Rasch model fit
Analysis Item ﬁt residual Person ﬁt residual C
Mean SD Mean SD Val
Pain subset
1 0.298 0.983 0.366 1.129 12
2 0.179 0.321 0.425 1.090 8
Function subset
3 0.020 1.605 0.362 1.589 57
4 0.057 1.603 0.286 1.325 49
5 0.024 1.521 0.314 1.262 30
6 0.103 1.229 0.304 1.264 27
Combined pain and reduced function subsets
7 0.118 1.361 0.267 1.406 50
8 0.086 1.226 0.255 1.333 43
9 0.111 1.045 0.318 1.286 25getting out of bed), implying local response dependency.
Item 11 was thus removed from the construct and the ﬁt
statistics recalculated. Analysis 9 in Table III shows a nearly
perfect ﬁt to the Rasch model on the item level and ade-
quate ﬁt on the person level, which is further supported by
the non-signiﬁcant chi square statistic (i.e., no signiﬁcant
deviation from the model). A PSI of 0.93 indicates a high
internal consistency reliability for use at the individual
patient level. Analysis of DIF revealed no differences
among all person factors speciﬁed. A ﬁnal test of unidimen-
sionality indicated signiﬁcant t tests at 6.62% (nine out of
136 samples), with a binomial conﬁdence interval lower
bound of 0.03. Thus, the t tests fall in the acceptable range
and the scale can be assumed to be unidimensional.ANALYSIS OF DIF FOR COMBINED 12-ITEM SCOREIt is pivotal that individual items in a score do not show
DIF between person factors. In other words, the expected
responses to an item should not be different between
patients with FAI or OA, between patients which do sports
or not do sports or between different age groups or gender.
None of the items in the 12-item score showed any DIF for
all four person factors speciﬁed. The 12-item score there-
fore can be used for measurement irrespective of diagnosis
or activity level, thus allowing for valid comparisons
between the different patient groups.
In the patient group studied here, the summed 12-item
score indicates different levels of discomfort for person
factors sports and disease, but not for gender or age. The
patients who participate in sports (FAI and OA patients)
have signiﬁcantly lower levels of complaint (mean logit
2.222; SD 1.58) than patients who do not (mean logit
0.709; SD 1.87; P¼<0.001). As would be expected,
patients with FAI (mean logit 2.266; SD 1.76) also have
signiﬁcant lower levels of complaint than OA patientsII
statistics
hi square interaction PSI t Tests (CI) (%) n
ue (df) P
.438 0.256809 0.8841 2.99 138
.640 0.373599 0.86906 3.01 137
.089 0.00413 0.9556 18.44 142
.818 0.012953 0.9540 16.79 139
.618 0.1042 0.93770 6.82 137
.618 0.118749 0.93040 3.79 137
.724 0.018959 0.94062 13.89 147
.973 0.047964 0.94132 11.43 140
.534 0.377236 0.93125 6.62 139
Table IV
Item fit residuals
Item Fit residual Chi square Probability
Pain subset
Pain at night 1.046 4.168 0.12443
Pain standing 0.889 4.55 0.102803
Pain sitting 1.533 0.8 0.670314
Pain walking ﬂat 0.07 2.684 0.261362
Pain negotiating stairs 0.268 0.236 0.888517
Function subset
Sitting 1.886 5.358 0.068646
Arising from sitting 2.232 4.900 0.086312
Getting out of bed 0.234 0.208 0.901444
Standing 1.211 3.689 0.158118
Getting in/out of bath 0.391 3.505 0.173359
Shopping 0.525 0.840 0.657042
Walking on ﬂat surface 1.362 5.688 0.058180
Getting in/out of car 0.290 0.228 0.892140
Going upstairs 0.680 1.669 0.434108
Going downstairs 0.904 1.534 0.464342
Combined construct




Pain negotiating stairs 0.956 1.722 0.422745
Sitting 0.669 2.166 0.338596
Arising from sitting 1.407 3.604 0.164933
Standing 0.645 0.777 0.678035
Getting in/out of bath 0.907 4.497 0.105539
Shopping 0.995 1.978 0.371953
Walking on ﬂat surface 0.112 2.828 0.243199
Getting in/out of car 0.986 1.602 0.448970
Ascending stairs 1.206 5.414 0.066737
Descending stairs 1.794 2.547 0.279834
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son is valid because it was shown that the 12 items have
no DIF in these groups.COMPARISON OF NORMAL AGE- AND GENDER-MATCHED
POPULATION TO FAI PATIENT POPULATION AND
OA POPULATIONThe logit values were transformed back onto a scale of
0e47 for the 12 items in RUMM2020. As the Kolmogorove
Smirnof test did not indicate signiﬁcant deviation fromFig. 2. ICC showing DIF of the item ‘‘pain sitting’’ in FAI vs OA
patients. This item had to be discarded in the total construct for
this reason.normality (P¼ 0.238) and Rasch analysis transformed the
ordinal manifest scores into an undimensional and linear
measure, summation and the use of parametric statistics
were valid. The scores for the normal patient population
(mean 0.39; SD 2.90; n¼ 200) were signiﬁcantly lower
than the scores of the FAI patients (mean 8.32; SD 7.32;
n¼ 100; t¼8.5269, P< 0.001) (Fig. 3). An effect size of
r¼ 0.71 was calculated. At a value above 0.5, the effect
size indicates that there is a large difference between the
patient and control population. The 12-item scale can
therefore be expected to record relief of symptoms as well
as aggravation. The transformed score of the OA group
(mean 16.23; SD 8.04; n¼ 57) is signiﬁcantly higher than
the FAI group (t¼7.7034, P< 0.001), as was already
indicated by the signiﬁcant ANOVA above. With the
P-values this low, they are also far below the Bonferroni
adjustement for multiple testing.ANALYSIS OF POST-HOC STATISTICAL POWERBased on the effect size of 0.71 and the signiﬁcance level
of 0.05, a statistical power of 0.999983 was calculated for the
two patient populations (control, n¼ 200; FAI, n¼ 100). This
indicates that the probability of a type II error is less than
0.0001 and therefore far below the accepted 0.2. The high
PSI of 0.93 and the high statistical power of downstream
analysis of the raw score for FAI patients vs the control
population provides evidence that the 12-item score can
reliably discriminate these groups with a very low probability
that a difference is not detected while present. This in
addition provides some external validity of the 12-item score,
in the sense that it records the level of discomfort of patients
with clinically manifest FAI, but does not indicate any level of
discomfort in the normal control population. For the OA
population compared to FAI, statistical power is not asFig. 3. Comparison of the 12-item score between groups. Scores
for the control population (mean 12.39; SD 2.90; n ¼ 200) are
signiﬁcantly lower than the score of the FAI group (mean 20.32;
SD 7.32; n¼ 100; P< 0.001), which in turn are signiﬁcantly lower
than the OA group’s scores (mean 28.23; SD 8.04; n¼ 57). Bars
represent mean values and error bars SDs.
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0.45, but still within acceptable range.Discussion
As orthopaedic interventions improve, and offer the
opportunity for early interventions, the need grows for valid
outcome scales to demonstrate the efﬁcacy of such
interventions, for example, for FAI. The WOMAC is one of
the most widely used outcome scales for hip OA and thus
provides an ideal starting point for this quest. Initially, a mod-
iﬁed version of this scale was used (7-point Likert), on the
assumption that milder disease will require more sensitive
scoring options. This proved to be a false assumption, as
patients could not discriminate between the options, and
disordered thresholds resulted, requiring rescoring of the
items to yield ordered response options.
Likewise a ‘total’ WOMAC score for this group was not
possible, despite other ﬁndings to the contrary18e20. The
analysis of the total original score shows both misﬁt to the
model as well as multidimensionality and therefore violates
the fundamental requirements for summating a scale, i.e.,
unidimensionality. The analysis then concentrated on sepa-
rate pain and function subsets, which showed adequate ﬁt
to the model for the former, but proved problematic for the lat-
ter, requiring item reduction. This arose mostly from item ﬁt or
the strict tests of unidimensionality which were adopted,
rather than from DIF which was largely absent. It has recently
been observed that even slight multidimensionality can affect
person estimates21, emphasising the vigilance necessary to
obtain a unidimensional scale. Only after reducing the func-
tion items, i.e., discarding items which cause misﬁt or intro-
duce multidimensionality, ﬁt to the model and
unidimensionality could be shown for the 10 remaining items
of the function subset. Summation of the 15 items of the pain
and reduced function subset into a total score introduced
multidimensionality besides some misﬁt to the Rasch model,
thus requiring further reduction to 12 items which show
a good model ﬁt as well as an unidimensional construct.
A previous study on Rasch analysis of the WOMAC
compared hip or knee arthroplasty patients over 55 years
of age pre- and post-operatively vs a community sample18.
Model ﬁt for the pain subset was achieved by reducing it to
three items, discarding night pain and pain on standing. The
functional subset also had to be reduced to 14 items by
omitting heavy domestic duties, getting in and out of the
bath, getting on and off the toilet. It was concluded that
the reduced WOMAC ﬁts the Rasch model. Unidimension-
ality was only shown for each subset and not for the whole
construct. Likewise, Ryser et al.19 evaluated a German
visual analogue version of the WOMAC in patients with
OA of the hip and knee in a rehabilitation program and
concluded that the WOMAC ﬁts the Rasch model except
for the item ‘pain at night’. While these earlier reports of
Rasch analysis on the WOMAC have also led to a reduced
scale and a presumptive model ﬁt for that particular popula-
tion, stricter tests of the unidimensionality assumption have
been recently introduced21, which are the underlying basis
of the present investigation. Applying such stringent criteria
to the WOMAC shows not only model misﬁt but also
multidimensionality. As indicated by our results, summing
the separate subscales that have been shown to ﬁt the
Rasch model does not necessarily lead to a higher con-
struct with the same validity. In our case, more changes
had to be made in order to obtain a scale which shows
the fundamental properties of model ﬁt andunidimensionality. While theWOMACwas devised as a mul-
tidimensional scale, summation of the subsets was sug-
gested upon its introduction22,23. However, the total item
set from the original WOMAC does not appear to ﬁt the
Rasch model without modiﬁcation, and thus calculating
and reporting a total summation score is not valid.
To our knowledge, only one novel scale has been proposed
for assessment of patients with FAI which at the same time
makes use of more adequate, contemporary methods such
as item response theory (IRT) rather than classical test the-
ory24. Although the authors’ methodology involved factor
analysis in the ﬁrst step, which requires normally distributed
interval-level data that cannot be expected from the ordinal
raw score, their study addresses the need for sound contem-
porary concepts in validating outcome measures.
Traditional evaluation, i.e., classical test theory, of
outcome scales involves testing for properties such as reli-
ability, validity and responsiveness25,26. Yet a requirement
for any scale is that the items form a unidimensional set.
Previously, factor analytic techniques have been occasion-
ally used to test this, but technically such procedures
require interval scaled data, not the ordinal data derived
from questionnaires. Rasch analysis uses ordinal data,
but the principal components analysis it uses is based
upon the ﬁt residuals, which are interval scaled. Conse-
quently, this approach provides a sound approach to testing
the unidimensionality of a set of items yielding ordinal data.
Furthermore, when data satisfy Rasch model requirements,
the approach transforms ordinal manifest data to latent
interval-level data, which allows for the comparison of
control, FAI and OA patients and the use of parametric
statistics (given appropriate distributions) and calculation
of change scores and effect sizes27.
The present WOMAC-based 5-item pain scale, and
10-item function scale, together with the 12-item summary
WOMAC scale, meet Rasch model expectations and are
strictly unidimensional, and can be used with conﬁdence
to compare FAI with OA patients. If a total score is to be re-
ported, only the 12-item scale should be used as the 5-pain
and 10-function items cannot be added. Comparing FAI
with OA is of particular interest, because this should allow
the monitoring of either relief of symptoms of FAI or the pro-
gression into manifest OA. While it has been demonstrated
that the scale can clearly discriminate between FAI and the
normal population with adequate statistical power, further
work is required to demonstrate that the scales are sensitive
enough to measure post-operative improvement in FAI pa-
tients and that such improvement is not indicated while not
being present. However, the level of reliability of the scales
and the statistical power shown indicate that this will be the
case. In addition, external construct validity is suggested by
comparing FAI to control patients as well as to the OA
patient population, both of which are discriminated with
adequate statistical power as well as effect sizes. It remains
to be shown, however, that this is also the case for a sepa-
rate 12-item questionnaire rather than just picking the 12
items out of the full scale in future investigations. While
the 12-item scale is unidimensional, similar questions
have been selected, e.g., negotiating stairs, from the pain
as well as functional subset of WOMAC questions. Local
dependency for these questions could not be shown and
should therefore not falsely inﬂate the reliability of the scale.
However, repetitively probing the same type of discomfort
may limit a scale’s magnitude by which a clinical entity
can be recorded, which has to be investigated in the future.
In summary, this is the ﬁrst report to the authors’
knowledge investigating unidimensionality of the WOMAC
1038 D. A. Rothenﬂuh et al.: 12-item WOMAC for FAI and OAwith stringent criteria10,21 concluding that summation of
a total score for patients with FAI and OA of the hip is not
valid. When the 12-item scale is used, the score yields
interval-level data which may be used in parametric statisti-
cal testing, because ﬁt to the Rasch model has been shown,
irrespective of person factors such as age, gender or sports
activities. The results in this study provide evidence for
external and prove internal construct validity for the
12-item scale with adequate discrimination of the different
populations probed.Conﬂict of interest
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